3 documents found, page 1 of 1

Sort by Issue Date

Real-world data from the Portuguese Nivolumab Expanded Access Program (EAP) in ...

Figueiredo, A.; Almeida, M.A.; Almodovar, M.T.; Alves, P.; A, Araujo; Araújo, D.; Barata, F.; Barradas, L.; Barroso, A.; Brito, U.; Camacho, E.

Objective: The main aim of the study was to evaluate the efficacy and safety profile of Nivolumab, an immune-checkpoint-inhibitor antibody, in advanced, previously treated, Non-Small Cell Lung Cancer (NSCLC) patients, in a real world setting. Methods: We performed a retrospective, multicentre data analysis of patients who were included in the Portuguese Nivolumab Expanded Access Program (EAP). Eligibility crite...


The potential offshore energy cluster in Portugal

Pego, A.; Marques, M.; Salvador, R.; Soares, Carlos Guedes; Monteiro, Ana


Reacção subclínica do pulmão profundo à amioderona

Freitas, M. S.; Pego, A.; Cordeiro, C. Robalo; Morais, M. E.; Lima, M. A.; Sousa, A.; Macedo, M.; Teixeira, A. M.; Nogueira, L. M.; Neite, I.


3 Results

Queried text

Refine Results

Author





















Date




Document Type



Access rights



Resource